Sean Ellis - 01 Jan 2022 Form 3/A - Amendment Insider Report for Entera Bio Ltd. (ENTX)

Role: Director
Signature: /s/ Dana Yaacov-Garbeli, Attorney-in-fact
Issuer symbol: ENTX
Transactions as of: 01 Jan 2022
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 25 Jul 2022, 17:23:44 UTC
Date Of Original Report: 14 Jan 2022
Next filing: 25 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ENTX	Ordinary Shares, par value NIS 0.0000769 per share						7,200	01 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ENTX	Warrants (right to buy)							01 Jan 2022	Ordinary Shares, par value NIS 0.0000769 per share	3,000	$5.85	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 3 amendment is being filed to correct the original Form 3 filed on January 14, 2022. The original Form 3 inadvertently omitted ordinary shares directly held by the Reporting Person.
F2	This Form 3 amendment is being filed to correct the original Form 3 filed on January 14, 2022. The original Form 3 inadvertently omitted warrants to purchase ordinary shares directly held by the Reporting Person.